Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2009 Filed Aug 21, 2009 17:30 UTC |
STEERE WILLIAM C JRDirector
|
SaleCommon Stock | 26,300 | $16.42 | $431,846.00 |
DisclosureSEC source: 0000078003-09-000180 · ste2124.xml · nonDerivative · entry 2 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,554,861 Read SEC document |
| August 21, 2009 Filed Aug 21, 2009 17:30 UTC |
STEERE WILLIAM C JRDirector
|
SaleCommon Stock | 1,623 | $16.41 | $26,633.43 |
DisclosureSEC source: 0000078003-09-000180 · ste2124.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,581,161 Read SEC document |
| August 18, 2009 Filed Aug 18, 2009 21:00 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
SaleCommon Stock | 20,000 | $15.99 | $319,800.00 |
DisclosureSEC source: 0000078003-09-000179 · can2123.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,659 Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 108 | $15.77 | $1,703.16 |
DisclosureSEC source: 0000078003-09-000171 · can2114.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,836 Underlying: Common Stock · 108 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 201 | $15.77 | $3,169.77 |
DisclosureSEC source: 0000078003-09-000172 · dam2115.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,573 Underlying: Common Stock · 201 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 637 | $15.77 | $10,045.49 |
DisclosureSEC source: 0000078003-09-000173 · kin2116.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,744 Underlying: Common Stock · 637 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 182 | $15.77 | $2,870.14 |
DisclosureSEC source: 0000078003-09-000174 · mac2117.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,226 Underlying: Common Stock · 182 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 962 | $15.77 | $15,170.74 |
DisclosureSEC source: 0000078003-09-000175 · rea2118.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,524 Underlying: Common Stock · 962 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 366 | $15.77 | $5,771.82 |
DisclosureSEC source: 0000078003-09-000176 · ric2119.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,811 Underlying: Common Stock · 366 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 213 | $15.77 | $3,359.01 |
DisclosureSEC source: 0000078003-09-000177 · rin2120.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,692 Underlying: Common Stock · 213 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2009 Filed Aug 18, 2009 15:31 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 126 | $15.77 | $1,987.02 |
DisclosureSEC source: 0000078003-09-000178 · sus2121.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,702 Underlying: Common Stock · 126 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 04, 2009 Filed Feb 11, 2010 15:23 UTC |
SANGER STEPHEN WDirector
|
GiftCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-003980 · doc4.xml · nonDerivative · entry 3 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for Spouse Disclosed balance after: 85 F1 · kind: These transactions represent the transfer of shares by the reporting person and his spouse to a trust for the benefit of spouse. Read SEC document |
| August 04, 2009 Filed Feb 11, 2010 15:23 UTC |
SANGER STEPHEN WDirector
|
GiftCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-003980 · doc4.xml · nonDerivative · entry 2 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 F1 · kind: These transactions represent the transfer of shares by the reporting person and his spouse to a trust for the benefit of spouse. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 70 | $15.93 | $1,115.10 |
DisclosureSEC source: 0000078003-09-000163 · can2105.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,728 Underlying: Common Stock · 70 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 125 | $15.93 | $1,991.25 |
DisclosureSEC source: 0000078003-09-000164 · dam2106.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,372 Underlying: Common Stock · 125 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 187 | $15.93 | $2,978.91 |
DisclosureSEC source: 0000078003-09-000165 · kin2107.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,107 Underlying: Common Stock · 187 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 119 | $15.93 | $1,895.67 |
DisclosureSEC source: 0000078003-09-000166 · mac2108.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,044 Underlying: Common Stock · 119 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 310 | $15.93 | $4,938.30 |
DisclosureSEC source: 0000078003-09-000167 · rea2109.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,562 Underlying: Common Stock · 310 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 82 | $15.93 | $1,306.26 |
DisclosureSEC source: 0000078003-09-000168 · ric2110.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,445 Underlying: Common Stock · 82 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 155 | $15.93 | $2,469.15 |
DisclosureSEC source: 0000078003-09-000169 · rin2111.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,479 Underlying: Common Stock · 155 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2009 Filed Aug 4, 2009 15:10 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 88 | $15.93 | $1,401.84 |
DisclosureSEC source: 0000078003-09-000170 · sus2112.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,576 Underlying: Common Stock · 88 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:54 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 75 | $15.02 | $1,126.50 |
DisclosureSEC source: 0000078003-09-000151 · can2097.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Underlying: Common Stock · 75 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:56 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 131 | $15.02 | $1,967.62 |
DisclosureSEC source: 0000078003-09-000152 · dam2098.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,247 Underlying: Common Stock · 131 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:56 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 126 | $15.02 | $1,892.52 |
DisclosureSEC source: 0000078003-09-000154 · mac2100.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,925 Underlying: Common Stock · 126 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:56 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 196 | $15.02 | $2,943.92 |
DisclosureSEC source: 0000078003-09-000153 · kin2099.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,920 Underlying: Common Stock · 196 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:56 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 332 | $15.02 | $4,986.64 |
DisclosureSEC source: 0000078003-09-000155 · rea2101.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,252 Underlying: Common Stock · 332 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:56 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 87 | $15.02 | $1,306.74 |
DisclosureSEC source: 0000078003-09-000156 · ric2102.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,363 Underlying: Common Stock · 87 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:56 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 165 | $15.02 | $2,478.30 |
DisclosureSEC source: 0000078003-09-000157 · rin2103.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,324 Underlying: Common Stock · 165 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2009 Filed Jul 16, 2009 19:57 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 93 | $15.02 | $1,396.86 |
DisclosureSEC source: 0000078003-09-000158 · sus2104.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,488 Underlying: Common Stock · 93 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
BURNS M ANTHONYDirector
|
Exercise / conversionPhantom Stock Units · Derivative | 27,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000144 · bur2089.xml · derivative · entry 2 BURNS M ANTHONY · CIK 0001174476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,285 Underlying: Common Stock · 27,950 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F1 · derivative.expiration_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
BURNS M ANTHONYDirector
|
Exercise / conversionCommon Stock | 27,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000144 · bur2089.xml · nonDerivative · entry 1 BURNS M ANTHONY · CIK 0001174476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
BURT ROBERT NDirector
|
Exercise / conversionPhantom Stock Units · Derivative | 22,496 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000145 · bur2092.xml · derivative · entry 3 BURT ROBERT N · CIK 0001051322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,708 Underlying: Common Stock · 22,496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F1 · derivative.expiration_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
BURT ROBERT NDirector
|
Disposition to issuerCommon Stock | 22,496 | $14.90 | $335,190.40 |
DisclosureSEC source: 0000078003-09-000145 · bur2092.xml · nonDerivative · entry 2 BURT ROBERT N · CIK 0001051322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,200 F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
BURT ROBERT NDirector
|
Exercise / conversionCommon Stock | 22,496 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000145 · bur2092.xml · nonDerivative · entry 1 BURT ROBERT N · CIK 0001051322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
CORNWELL W DONDirector
|
Exercise / conversionPhantom Stock Units · Derivative | 31,502 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000146 · cor2093.xml · derivative · entry 4 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,868 Underlying: Common Stock · 31,502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F3 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F1 · derivative.expiration_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
CORNWELL W DONDirector
|
Disposition to issuerCommon Stock | 31,502 | $14.90 | $469,379.80 |
DisclosureSEC source: 0000078003-09-000146 · cor2093.xml · nonDerivative · entry 2 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
CORNWELL W DONDirector
|
Exercise / conversionCommon Stock | 31,502 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000146 · cor2093.xml · nonDerivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
GRAY III WILLIAM HDirector
|
Exercise / conversionPhantom Stock Units · Derivative | 23,237 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000147 · gra2094.xml · derivative · entry 3 GRAY III WILLIAM H · CIK 0001140889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,679 Underlying: Common Stock · 23,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F1 · derivative.expiration_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
GRAY III WILLIAM HDirector
|
Disposition to issuerCommon Stock | 23,237 | $14.90 | $346,231.30 |
DisclosureSEC source: 0000078003-09-000147 · gra2094.xml · nonDerivative · entry 2 GRAY III WILLIAM H · CIK 0001140889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26 F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
GRAY III WILLIAM HDirector
|
Exercise / conversionCommon Stock | 23,237 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000147 · gra2094.xml · nonDerivative · entry 1 GRAY III WILLIAM H · CIK 0001140889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
LORCH GEORGE ADirector
|
Exercise / conversionPhantom Stock Units · Derivative | 22,376 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000148 · lor2090.xml · derivative · entry 2 LORCH GEORGE A · CIK 0001174481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,762 Underlying: Common Stock · 22,376 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F1 · derivative.expiration_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
LORCH GEORGE ADirector
|
Exercise / conversionCommon Stock | 22,376 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000148 · lor2090.xml · nonDerivative · entry 1 LORCH GEORGE A · CIK 0001174481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
MEAD DANA GDirector
|
Exercise / conversionPhantom Stock Units · Derivative | 41,926 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000149 · mea2095.xml · derivative · entry 3 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,534 Underlying: Common Stock · 41,926 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F1 · derivative.expiration_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
MEAD DANA GDirector
|
Disposition to issuerCommon Stock | 41,926 | $14.90 | $624,697.40 |
DisclosureSEC source: 0000078003-09-000149 · mea2095.xml · nonDerivative · entry 2 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,350 F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
MEAD DANA GDirector
|
Exercise / conversionCommon Stock | 41,926 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000149 · mea2095.xml · nonDerivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in cash, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionPhantom Stock Units · Derivative | 36,988 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000150 · ste2091.xml · derivative · entry 3 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,955 Underlying: Common Stock · 36,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F3 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. F1 · derivative.expiration_date: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| July 01, 2009 Filed Jul 2, 2009 17:00 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 36,988 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000150 · ste2091.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,582,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As disclosed in the Company's Proxy Statement in connection with its 2009 Annual Meeting of Shareholders, the transactions that are reported in this Form 4 were effected pursuant to an election made by the reporting person in December 2008 under Section 409A of the Internal Revenue Code ("Section 409A"). Section 409A provided a one-time opportunity to accelerate the payment of compensation that had been deferred in 2005 through 2008 (together with any related earnings). The transactions reported herein consist of the acceleration of the payment, in the form of Pfizer common stock, of compensation that had been deferred by the reporting person in 2005 through 2008 (including dividend equivalents thereon) under certain plans for non-employee directors. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 20:24 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 73 | $15.00 | $1,095.00 |
DisclosureSEC source: 0000078003-09-000136 · can2078.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,583 Underlying: Common Stock · 73 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 20:24 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 130 | $15.00 | $1,950.00 |
DisclosureSEC source: 0000078003-09-000137 · dam2079.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,116 Underlying: Common Stock · 130 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 20:24 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 180 | $15.00 | $2,700.00 |
DisclosureSEC source: 0000078003-09-000138 · kin2081.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,724 Underlying: Common Stock · 180 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.